IL313964A - METHODS FOR THE LARGE-SCALE SYNTHESIS OF RADIONUCLIDE COMPLEXES - Google Patents

METHODS FOR THE LARGE-SCALE SYNTHESIS OF RADIONUCLIDE COMPLEXES

Info

Publication number
IL313964A
IL313964A IL313964A IL31396424A IL313964A IL 313964 A IL313964 A IL 313964A IL 313964 A IL313964 A IL 313964A IL 31396424 A IL31396424 A IL 31396424A IL 313964 A IL313964 A IL 313964A
Authority
IL
Israel
Prior art keywords
methods
large scale
scale synthesis
radionuclide complexes
radionuclide
Prior art date
Application number
IL313964A
Other languages
English (en)
Hebrew (he)
Inventor
Donato Barbato
Michele Bo
Mattia Rossetto
Mattia Tedesco
Federico Valerio
Original Assignee
Advanced Accelerator Applications
Donato Barbato
Michele Bo
Mattia Rossetto
Mattia Tedesco
Federico Valerio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Accelerator Applications, Donato Barbato, Michele Bo, Mattia Rossetto, Mattia Tedesco, Federico Valerio filed Critical Advanced Accelerator Applications
Publication of IL313964A publication Critical patent/IL313964A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL313964A 2022-02-04 2023-02-03 METHODS FOR THE LARGE-SCALE SYNTHESIS OF RADIONUCLIDE COMPLEXES IL313964A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263306822P 2022-02-04 2022-02-04
PCT/IB2023/050982 WO2023148680A1 (en) 2022-02-04 2023-02-03 Methods for large scale synthesis of radionuclide complexes

Publications (1)

Publication Number Publication Date
IL313964A true IL313964A (en) 2024-08-01

Family

ID=85221934

Family Applications (1)

Application Number Title Priority Date Filing Date
IL313964A IL313964A (en) 2022-02-04 2023-02-03 METHODS FOR THE LARGE-SCALE SYNTHESIS OF RADIONUCLIDE COMPLEXES

Country Status (9)

Country Link
US (1) US20260053959A1 (cg-RX-API-DMAC7.html)
EP (1) EP4472678A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025506322A (cg-RX-API-DMAC7.html)
KR (1) KR20240146015A (cg-RX-API-DMAC7.html)
CN (1) CN118159303A (cg-RX-API-DMAC7.html)
CA (1) CA3235923A1 (cg-RX-API-DMAC7.html)
IL (1) IL313964A (cg-RX-API-DMAC7.html)
TW (1) TW202342112A (cg-RX-API-DMAC7.html)
WO (1) WO2023148680A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024317528A1 (en) * 2023-07-31 2026-03-05 Curium Us Llc [177 lu] lutetium-psma it composition and dosimetry, kit, method of making, and method of using thereof
WO2025210599A2 (en) 2024-04-05 2025-10-09 Novartis Ag Combination therapies with dna damage response inhibitors and [ 177lu]lu-psma-617
WO2026088112A1 (en) 2024-10-23 2026-04-30 Novartis Ag Combination therapies with ar-degrading agents and psma-targeting radioligands
WO2026099626A1 (en) 2024-11-08 2026-05-15 Novartis Ag Methods and systems for manufacturing radiopharmaceuticals
WO2026120497A1 (en) 2024-12-05 2026-06-11 Novartis Ag Stable radionuclide complex solutions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7358451B2 (ja) * 2018-07-25 2023-10-10 アドバンスド アクセラレーター アプリケーションズ 安定な濃厚放射性核種錯体溶液
IL280314B1 (en) * 2018-07-25 2026-07-01 Advanced Accelerator Applications Sa Stable and concentrated radionuclide complex solutions
WO2020079799A1 (ja) 2018-10-18 2020-04-23 三菱電機株式会社 付加製造加工機および冷却方法
CN112969675B (zh) * 2018-10-31 2024-12-20 意大利国际先进加速器应用有限公司 用于合成放射性核素络合物的方法
MX2021015467A (es) * 2019-06-14 2022-01-24 Edinburgh Molecular Imaging Ltd Compuestos y metodos de uso.

Also Published As

Publication number Publication date
KR20240146015A (ko) 2024-10-07
CA3235923A1 (en) 2023-08-10
WO2023148680A1 (en) 2023-08-10
US20260053959A1 (en) 2026-02-26
EP4472678A1 (en) 2024-12-11
CN118159303A (zh) 2024-06-07
TW202342112A (zh) 2023-11-01
JP2025506322A (ja) 2025-03-11

Similar Documents

Publication Publication Date Title
IL282701B2 (en) Methods for the synthesis of a radionuclide complex
GB2637892B (en) Methods for paired-end sequencing library preparation
IL305751A (en) SYNTHESIS OF OMECAMTIV MECARBIL
IL292210A (en) An efficient process for the synthesis of 2-amino-5-chloro-n,3-dimethylbenzamide
IL287499A (en) Compounds for use in the synthesis of peptidomimetic compounds
GB202004665D0 (en) Process for the synthesis of ethylene glycol
IL311128A (en) Synthesis of neurogestate
IL297180A (en) Process for synthesizing sulfonated triaryl methane compounds
PL4076724T3 (pl) Reaktor łączony do wysoko-ciśnieniowej syntezy melaminy
GB2616849B (en) Improved synthesis
GB202202880D0 (en) Methods for peptide synthesis
GB2620465B (en) Synthesis method of indole organophosphorus compound
GB201903055D0 (en) Method of oligonucleaotide synthesis
GB202306433D0 (en) Amine synthesis
IL307826A (en) Processes for the synthesis of valbanazine
GB2617952B (en) Method or process for ferrate synthesis
GB202211474D0 (en) Methods of synthesis
IL317021A (en) Synthesis of fluorosilyl compounds
GB202118156D0 (en) Methods of synthesis
GB202118099D0 (en) Methods of synthesis
GB202118005D0 (en) Methods of synthesis
IL312336A (en) Synthesis of materials that form restrained complexes
GB202212113D0 (en) Method of synthesis
GB202212117D0 (en) Method of synthesis
IL321707A (en) Synthesis of 2-phenyl-2-amino-cyclohexan-1-one history